Skip to main content
. 2022 Feb 24;2022:2022657. doi: 10.1155/2022/2022657

Table 2.

The results of univariate analysis.

Statistics Effect size (HR, 95% CI) p value
Age 66.95 ± 12.16 1.01 (0.99, 1.02) 0.2427
Gender
 Female 33 (27.97%) Ref
 Male 85 (72.03%) 1.55 (1.03, 2.33) 0.0353
HBP
 No 46 (38.98%) Ref
 Yes 72 (61.02%) 0.90 (0.62, 1.31) 0.5881
DM
 No 77 (65.25%) Ref
 Yes 41 (34.75%) 0.86 (0.59, 1.27) 0.4525
Previous MI
 No 99 (83.90%) Ref
 Yes 19 (16.10%) 1.25 (0.76, 2.06) 0.3739
Anterior wall MI
 No 46 (38.98%) Ref
 Yes 72 (61.02%) 1.01 (0.69, 1.46) 0.9723
SBP 132.22 ± 26.59 1.00 (0.99, 1.01) 0.8123
HR 79.48 ± 18.51 1.00 (0.99, 1.02) 0.3959
WBC 10.60 ± 3.86 0.84 (0.79, 0.89) <0.0001
Neutrophil 76.76 ± 12.56 1.01 (0.99, 1.02) 0.3747
Hemoglobin 139.42 ± 16.66 1.00 (0.99, 1.01) 0.9739
Platelet 240.18 ± 60.08 1.00 (1.00, 1.00) 0.3973
PNR 34.90 ± 17.25 1.02 (1.01, 1.04) <0.0001
BUN 6.78 ± 1.88 0.97 (0.88, 1.07) 0.5292
Creatinine 76.28 ± 15.64 1.02 (1.01, 1.03) 0.0031
eGFR 0.40 ± 0.12 0.21 (0.05, 0.91) 0.0374
Uric acid 333.34 ± 80.66 1.00 (1.00, 1.00) 0.0440
Albumin 37.88 ± 3.91 0.99 (0.94, 1.04) 0.7218
FBG 7.67 ± 2.68 0.96 (0.90, 1.03) 0.2573
TG 1.08 ± 0.65 0.86 (0.64, 1.14) 0.2891
TC 5.87 ± 0.99 1.16 (0.95, 1.41) 0.1450
HDL-C 1.25 ± 0.28 1.21 (0.59, 2.48) 0.6058
LDL-C 3.07 ± 0.72 0.92 (0.71, 1.21) 0.5636
Peak cTnI 18.47 ± 11.75 0.99 (0.98, 1.01) 0.4161
Peak CK-MB 133.20 ± 88.07 1.00 (1.00, 1.00) 0.9251
D-dimer 0.97 ± 0.88 0.92 (0.73, 1.16) 0.4907
LVEDD 51.98 ± 6.39 1.03 (1.00, 1.06) 0.0552
Apelin-12 0.71 ± 0.28 0.74 (0.38, 1.43) 0.3739
Apelin-12 change rate 12.31 ± 7.31 1.01 (0.99, 1.03) 0.4852
Culprit vessels
 LAD 64 (54.24%) Ref
 LCX 18 (15.25%) 0.95 (0.56, 1.62) 0.8642
 RCA 36 (30.51%) 1.18 (0.78, 1.78) 0.4428
Stent number 1.35 ± 0.55 1.06 (0.73, 1.54) 0.7415
Pathological Q wave
 No 48 (40.68%) Ref
 Yes 70 (59.32%) 1.09 (0.75, 1.58) 0.6475
Killip classification > 1
 No 77 (65.25%) Ref
 Yes 41 (34.75%) 1.47 (1.00, 2.17) 0.0509
GENSINI 75.98 ± 30.46 1.00 (0.99, 1.01) 0.7981